Srivatsan Ramesh

At BridgeBio, Srivatsan Ramesh is dedicated to advancing the development of scalable, cost-effective therapeutics through gene therapy for a range of genetic disorders and rare diseases. His responsibilities include refining the downstream purification processes for AAV-based gene therapies and investigating innovative technologies to streamline and strengthen the transition of therapies from development to clinical or commercial manufacturing. During his doctoral studies in Chemical Engineering at North Carolina State University, his research primarily concentrated on two areas: the synthesis of stimuli-responsive polymers for applications in membrane purification and drug delivery, as well as the development of biosensors for protein quantification.